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ABSTRACT 
Posttraumatic Stress Disorder (PTSD) has been primarily conceptualized as a 
fear-based disorder, but accumulating research indicates that shame can also strongly 
contribute to the development and maintenance of PTSD. Existing evidence-based 
treatments for PTSD typically focus on dysregulated fear responding and do not directly 
target the affective experience of shame. Interventions that promote self-compassion have 
shown promise for reducing shame related to various clinical problems, but this approach 
has not been systematically evaluated in traumatized individuals. The aim of this study 
was to develop and evaluate a brief compassion-based therapy, with the hypothesis that it 
would reduce trauma-related shame and PTSD symptoms. The intervention consisted of 
six weekly individual therapy sessions focused on promoting self-compassion in response 
to a traumatic event and its sequelae. Using a multiple baseline design, the intervention 
was evaluated in a community sample of trauma-exposed adults (N = 10) with elevated 
shame and PTSD symptoms. Participants completed assessments on a weekly basis 
during a 2-, 4-, or 6-week baseline phase and 6-week treatment phase, and at 2- and 4-
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weeks after the intervention. By the end of treatment, 90% of participants demonstrated 
reliable decreases in PTSD symptom severity (p < .05), while 80% of participants 
showed reliable reductions in shame (p < .05), relative to their respective scores at 
baseline. These improvements were maintained at 2- and 4-week follow-up, with large 
effect sizes for PTSD symptom severity (d = 2.26) and shame (d = 2.12), compared to 
scores at baseline. The intervention was also associated with improvements in self-blame 
(d = 2.61), self-compassion (d = 2.28), mindfulness (d = 2.21), positive affect (d = 1.07), 
and negative affect (d = 2.14). Greater increases in self-compassion from baseline to 
follow-up were correlated with greater reductions in PTSD symptom severity (r = -.76, p 
< .05) and in shame (r = -.79, p < .01). Participants reported high levels of satisfaction 
with the intervention. The results from the present study support the hypothesis that 
compassion-based therapy is associated with reductions in trauma-related shame and 
PTSD symptoms. The marked improvements observed during the relatively brief 
intervention suggest that the intervention may be useful as either a stand-alone treatment 
or as a supplement to other treatments.  
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INTRODUCTION 
The vast majority of individuals will experience one or more potentially traumatic 
events (PTEs) in their lifetime, including natural disasters, war, life-threatening accidents, 
interpersonal violence, and sexual assault (Kessler et al., 1995). Most individuals exposed 
to PTEs recover from initial distress, and many do not develop noteworthy impairment 
(Bonnano, 2004). However, depending on the severity and type of trauma, approximately 
8-54% develop chronic, pervasive problems including posttraumatic stress disorder 
(PTSD), depression, interpersonal difficulties, and functional impairment (e.g., Kessler et 
al., 1995). Current empirically supported treatments (ESTs) for PTSD, including trauma-
focused cognitive behavioral therapy (TF-CBT), are effective for many but not all trauma 
survivors. Meta-analysis has revealed that among individuals who receive established 
ESTs, 33-44% continue to meet criteria for PTSD, and the majority continue to suffer 
from symptoms that are subclinical yet nonetheless impairing (Bradley, Greene, Russ, 
Dutra, & Westen, 2005; Zlotnick, Franklin, & Zimmerman, 2002). In addition, 21-27% 
of individuals drop out of TF-CBT prematurely, in contrast to the 11% dropout rate for 
less effective but more tolerable treatments such as supportive counseling or relaxation 
training (Hembree et al., 2003). Furthermore, most ESTs primarily target dysregulated 
fear responses and over-accommodated beliefs about danger from life-threat trauma; they 
do not directly address other maladaptive reactions that are especially common after 
interpersonal trauma, including shame and self-blame (Litz et al., 2009; Vidal & Petrak, 
2007). Consequently, there is a need to develop additional treatments for PTSD. 
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Shame and PTSD 
To date, PTSD has been primarily conceptualized as caused by intensive fear 
conditioning and a failure of extinction. This scheme fits traumatic experiences that entail 
high fear and life-threat very well but fails to explain or address focal non-life-threat 
traumatic experiences and other aversive emotional repertoires, such as shame and guilt, 
which contribute to the development and maintenance of PTSD (Brewin et al., 2009; La 
Bash & Papa, 2014). Shame refers to the affective experience associated with global, 
negative self-evaluations (Lewis, 1971). The experience of shame entails feeling 
intrinsically defective, socially undesirable, inferior, and inadequate (i.e., “I am a bad 
person”). Shame is typically the result of inferred or actual condemning social evaluation 
(Dickerson, Gruenewald, & Kemeny, 2004). Deliberately-perpetrated interpersonal 
trauma (e.g., physical violence, sexual assault) can be an especially potent form of 
negative social evaluation and rejection. Threats to social esteem, acceptance, and 
standing are associated with shame, which is in turn associated with increased cortisol 
and pro-inflammatory cytokines, reduced motivation, and withdrawal (Dickerson et al., 
2004). While guilt is commonly confused with shame, guilt distinctly focuses on 
evaluations of a discrete behavior (“I did something bad”) rather than global evaluations 
of the self (Tangney, Stuewig, & Mashek, 2007). Although guilt motivates prosocial 
behaviors such as apology and reparation, shame typically motivates concealment and 
withdrawal (Tangney et al., 2007). Shame, but not guilt, is consistently associated with 
PTSD symptom severity in a variety of traumatized populations, including battered 
women, survivors of childhood abuse and neglect, and war veterans (Beck et al., 2011; 
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Chan, Hess, Whelton, & Yonge, 2005; Dorahy, 2010; Kleim, Graham, Bryant, & Ehlers, 
2013; Leskela et al., 2002; Robinaugh & McNally, 2010).  
Shame tends to persist over time and predicts poor posttraumatic outcomes. In 
response to interpersonal trauma, shame may be temporarily adaptive, akin to submissive 
behavior in animals that communicates a change in status, preserves group membership, 
and decreases the likelihood of continued aggression from others (Dickerson et al., 2004; 
Gilbert, 1997). However, the human capacity for self-conscious experience means that 
long after the external threat has ceased, trauma survivors can continue to perceive 
negative social evaluation and attack themselves with self-criticism, shame, and self-
blame (Andrews, Brewin, Rose, & Kirk, 2000; Gilbert, 1997; Lee, Scragg, & Turner, 
2001). Indeed, in a longitudinal study of abused adolescents, higher levels of shame at the 
time of the abuse discovery were associated with persistent abuse-related shame, as well 
as general shame proneness, six years later (Feiring & Taska, 2005). Controlling for 
abuse severity and initial symptom severity, event-related shame predicted overall PTSD 
symptom severity one year later and re-experiencing symptoms six years later (Feiring & 
Taska, 2005; Feiring, Taska, & Lewis, 2002). Cross-sectional studies have also found 
that higher levels of shame among trauma-exposed individuals are associated with greater 
PTSD symptom severity (Harman & Lee, 2010). Shame is also associated with other 
negative trauma-related outcomes, including self-blame among sexual assault survivors 
(Vidal & Petrak, 2007) and feeling disconnected from relationships (Dorahy, 2010).  
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Models of PTSD 
Theoretical models of PTSD, principally emotional-processing theory (Foa & 
Rothbaum, 1998), posit that PTSD arises from an over-generalized, overactive fear 
response. At the time of the trauma, strong associations are formed among trauma-related 
cues and emotional and physical reactions. Subsequently, a wide array of trauma-related 
cues can activate this entire fear network, resulting in re-experiencing and hyperarousal 
symptoms. These symptoms are maintained by avoidance of trauma-related cues, which 
negatively reinforces the associations in the fear network and prevents new, corrective 
information from being incorporated. Existing ESTs for PTSD, such as exposure therapy, 
primarily target dysregulated fear. Recent research, however, indicates that while fear is 
an important predictor of PTSD severity, shame is an equally strong, independent 
predictor (La Bash & Papa, 2014).  
The recognition that PTSD is not merely a fear-based disorder is reflected in the 
newest version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; 
APA, 2013). In the DSM-5, diagnosis of PTSD no longer requires signs of unconditioned 
peritraumatic responses, such as “intense fear, helplessness, or horror” (Criterion A2 of 
DSM-IV-TR; APA, 2000). In addition, the following three symptoms were added: (1) 
negative beliefs and expectations about oneself or the world, (2) distorted blame of self or 
others, and (3) persistent negative trauma-related emotions such as fear, horror, anger, 
guilt, or shame. 
More recent theoretical models of PTSD, including dual-representation theory 
(Brewin et al., 1996; Brewin, Gregory, Lipton, & Burgess, 2010) and cognitive theory 
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(Ehlers & Clark, 2000), may provide a framework for understanding how shame 
contributes to PTSD. According to cognitive theory, PTSD develops and is maintained by 
the perception of ongoing current threat (Ehlers & Clark, 2000). This threat can be 
external (i.e., seeing others as untrustworthy, seeing the world as unsafe) or internal (i.e., 
seeing oneself as damaged, inadequate, incapable, hopeless). While perceived external 
threats tend to evoke fear, internal threats can manifest as shame. Underscoring the 
relevance of internal threat, trauma-exposed individuals recalled more cognitions related 
to psychological threat to self (e.g., “There’s something wrong with me”) than cognitions 
regarding physical threat (e.g., “I’ll be killed”) when recalling their peak moments of 
distress during a traumatic event (Holmes, Grey, & Young, 2005; Grey & Holmes, 2008). 
Shame also motivates avoidant behaviors such as shrinking away, hiding, and concealing, 
which may further maintain PTSD symptoms. PTSD that is maintained by fear and an 
ongoing sense of external threat may be more responsive to exposure-based treatments. 
These treatments expose individuals to fear-inducing memories and situations in a safe 
environment, facilitating habituation and ultimately extinction of the conditioned fear 
response. Other cases of PTSD may be maintained by shame and may respond less well 
to exposure therapy (Harman & Lee, 2010).  
Both cognitive and dual-representation theories hypothesize that the way 
traumatic experience is encoded and processed by different memory systems contributes 
to the development and maintenance of PTSD (reviewed in Brewin et al., 2003). PTSD is 
said to occur when the trauma memory is poorly contextualized, which prevents adequate 
integration into consciously-accessible autobiographical memory (Ehlers & Clark, 2000; 
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Brewin et al., 1996, 2010). Instead, the traumatic event is over-represented in a sensory-
based memory system that automatically associates perceptual cues (e.g., sights and 
sounds at the time of the trauma) with strong physiological and emotional responses 
(Brewin et al., 1996, 2010). These theories imply that the most effective treatments will 
involve contextualizing the trauma memory while also creating new sensory-based 
representations linked to the trauma memory. Contextualizing the trauma with new 
appraisals (e.g., “What happened in the past was not my fault”) therefore may not be 
sufficient if they are not linked to new sensory-based information (e.g., feeling comforted 
and soothed). 
 
Addressing Shame in PTSD 
Reduced shame appears to aid recovery from PTSD. One study found that 
changes in abuse-related shame mediated the effect of psychotherapy on PTSD 
symptoms (Ginzburg et al., 2009). A recent study found that changes in shame during 
treatment predicted PTSD symptom severity at later time points (Øktedalen, Hoffart, & 
Langkaas, 2014). In a longitudinal observational study, reductions in shame were related 
to significant reductions in depression and PTSD and increases in self-esteem over the 
course of a year (Feiring et al., 2002). In contrast, individuals who experienced increased 
shame over time or maintained high levels of shame were more likely to suffer from 
clinically significant PTSD symptoms six years later (Feiring & Taska, 2005). These 
findings suggest that trauma treatments that reduce shame may lead to improved 
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outcomes. However, treatments that directly target shame in PTSD have not yet been 
systematically evaluated.  
 
Compassion 
In the past several years, there has been an increase in research on compassion, 
which is especially relevant for treating shame in PTSD. Compassion can be broadly 
defined as, “a sensitivity to the suffering of self and others with a deep commitment to try 
to relieve it” (Lama, 2001). The construct of compassion is closely related to mindfulness, 
which involves paying attention to immediate experience in the present, with an attitude 
of openness, curiosity, and acceptance (Bishop et al., 2004). However, whereas 
mindfulness entails awareness and nonjudgmental acceptance of experience with “open 
eyes”, compassion focuses on accepting the experiencer with an open heart (Germer & 
Neff, 2014; Neff & Germer, 2013). Compassion involves being mindfully aware of 
suffering, seeing the shared humanity of the person experiencing suffering, and turning 
towards the person with kindness, warmth, and goodwill, not to change their pain but 
because of their suffering (Neff, 2003; Neff & Germer, 2013). For individuals with PTSD 
and high shame, cultivating self-compassion could address pervasive feelings of 
unworthiness and insufficiency, while countering the behavioral tendencies to withdraw 
and self-criticize.  
Research has shown that self-compassion is positively associated with variables 
that are negatively affected by exposure to PTEs, including well-being, positive affect, 
and life satisfaction (Neff, 2003). Self-compassion is also negatively associated with 
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variables that frequently co-occur with PTSD, including depression, anxiety, and shame 
(Gilbert & Procter, 2006). Contrary to popular concerns that high self-compassion may 
foster self-pity, self-indulgence, or laziness, self-compassion is positively correlated with 
intrinsic motivation, assumption of responsibility in response to negative evaluation, and 
accurate self-perception (Leary, Tate, Adams, Batts Allen, & Hancock, 2007). In a recent 
meta-analysis, self-compassion was also found to be an important negative predictor of 
psychopathology (MacBeth & Gumley, 2012).  
Fortunately, self-compassion appears to be malleable; even brief compassion 
inductions in experimental settings can lead to short-term reductions in distress and 
shame, and increases in positive affect and connection with others (Johnson & O'Brien, 
2013; Leary et al., 2007). Longer term results have been observed in two recently-
developed, 8-12 week protocols for promoting self-compassion: Compassion Focused 
Therapy (CFT; Gilbert & Procter, 2006; Mayhew & Gilbert, 2008) and Mindful Self-
Compassion (MSC; Neff & Germer, 2013). In an uncontrolled study of a small clinical 
sample, a 12-week CFT intervention led to pre-post reductions in shame, depression, and 
anxiety (Gilbert & Procter, 2006). In a randomized controlled trial with a non-clinical 
sample, eight weeks of MSC led to statistically significant pre-post increases in self-
compassion, mindfulness, and life satisfaction, as well as decreases in depression, anxiety, 
and avoidance, compared to a waitlist control group (Neff & Germer, 2013). These gains 
were maintained 1-year post-treatment (Neff & Germer, 2013).  
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Compassion and PTSD 
Increasing compassion may reduce the shame and internal threat of evaluating 
oneself negatively, which maintain PTSD. Responding compassionately to one’s own 
suffering may activate the attachment and caregiving emotion regulation system, which 
triggers affiliative behavior, comfort, and soothing (Gilbert & Procter, 2006). Activating 
this system may reduce the perceived threat in PTSD, thereby increasing distress 
tolerance and decreasing avoidance behaviors that further maintain the disorder.  
Enhancing compassion may also reduce the internal threat of seeing oneself as 
damaged and unworthy by introducing new, corrective higher-level information (i.e., 
adaptive reappraisals of the trauma or its sequelae) as well as lower-level, sensory-based 
information. Compassion may diminish negative schemas of incompetence and 
defectiveness (i.e., “I deserved this. It’s my fault”) by promoting an appreciation of one’s 
common humanity and a desire to act kind toward oneself in moments of suffering (e.g., 
“No one deserves this. I can be kind and comfort myself when I feel this way, as I would 
with a good friend”; Gilbert & Proctor, 2006; Germer & Neff, 2014). Developing the 
capacity to be self-compassionate may also change negative appraisals of trauma-related 
sequelae (e.g., “There’s something wrong with me that I haven’t been able to get over 
this. I’m all alone”) by increasing appreciation of one’s common humanity and applying 
kindness and understanding towards the self (e.g., “Everyone experiences difficulties. I’m 
doing my best, just like everyone else”). In addition, learning to self-soothe in response to 
trauma-related distress may create new sensory-based, corrective information. Rather 
than relying primarily on higher-level reason and logic to challenge distorted cognitions 
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about oneself or the external world, cultivating compassion creates a felt-sense of 
safeness and caring (Gilbert, 2009). Internalizing these new sensory representations and 
making them very salient increases the likelihood that they will be preferentially retrieved 
relative to the old sensory representations of shame when exposed to trauma cues.  
Another potential benefit of compassion enhancement is redressing emotional 
numbing, a core component of PTSD, by increasing positive affect and feelings of social 
connectedness (Fredrickson et al., 2009; Thompson & Waltz, 2008). Emotional numbing 
entails deficits in emotional experience and expression, especially in the context of 
trauma reminders (Litz & Gray, 2001). The hyperarousal and re-experiencing symptoms 
triggered by trauma reminders tax working memory and diminish emotional resources for 
appetitive behaviors and positive states (Litz & Gray, 2001). By learning to respond 
compassionately towards themselves in the context of distress and perceived threat, 
individuals with PTSD may reduce the burden on their working memory and increase 
their capacity to experience and express positive emotion. 
Compassion interventions have not yet been systematically evaluated for reducing 
shame among individuals with PTSD, but a small number of observational studies have 
investigated the relationship between PTSD and compassion. Greater levels of self-
compassion were associated with fewer avoidance symptoms in an undergraduate sample, 
consistent with the notion that self-compassion may counteract avoidant tendencies 
(Thompson & Waltz, 2008). In two studies of veterans, greater self-compassion predicted 
lower PTSD severity and higher functioning (Dahm, 2013; Kearney et al., 2013). In 
prospective studies of individuals exposed to PTEs, self-compassion predicted PTSD 
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severity up to 12 months later, after controlling for factors such as degree of exposure to 
PTEs, baseline PTSD severity, and mindfulness (Hiraoka et al., 2015; Zeller, Yuval, 
Nitzan-Assayag, & Bernstein, 2014). In a sample of adolescents and young adults, 
childhood maltreatment was associated with lower self-compassion (Vettese, Dyer, Li, & 
Wekerle, 2011). Self-compassion mediated the relationship between maltreatment 
severity and emotion regulation difficulties, suggesting that increasing self-compassion 
may improve emotion regulation among traumatized individuals (Vettese et al., 2011). 
Another study found that individuals with high shame and PTSD reported a greater 
tendency to self-criticize and a lower tendency to self-reassure (Harman & Lee, 2010). 
Directly reducing shame by learning self-soothing and self-reassuring skills may 
therefore help individuals to tolerate and stay in treatment, as well as reduce the sense of 
internal threat that maintains PTSD (Harman & Lee, 2010; Lee et al., 2001). 
Only two studies to date have evaluated the efficacy of compassion-based 
therapies for PTSD, with promising results. One small study randomized participants 
(mostly civilian accident survivors) to receive either CBT or compassion-enhanced CBT, 
which involved engaging in exercises designed to increase self-compassion (Beaumont, 
Galpin, & Jenkins, 2012). Compared to CBT-only, compassion-enhanced CBT produced 
larger increases in self-compassion. Both therapies produced improvements in PTSD, 
depression, and anxiety symptom severity. In a recent open trial, veterans received 12 
weeks of instruction and practice in a single compassion-building technique: loving 
kindness meditation, a practice designed to enhance kindness and compassion for self and 
others (Kearney et al., 2013). This intervention was found to be safe and acceptable to 
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veterans and produced large reductions in PTSD symptoms, alongside large increases in 
self-compassion. Change in self-compassion mediated changes in PTSD symptom 
severity. However, since there was no control group it remains unknown whether 
symptoms may have improved with the passage of time. In addition, shame was not 
assessed in either of these studies. 
 
The Current Study 
In the present study, we developed a compassion-based intervention for elevated 
shame and PTSD symptoms. The intervention was designed to increase self-compassion, 
integrating research on PTSD with theory and techniques adapted from two existing self-
compassion interventions: Mindful Self-Compassion (MSC; Neff & Germer, 2013) and 
Compassion Focused Therapy (CFT; Gilbert & Procter, 2006), including a CFT protocol 
for recovering from trauma and PTSD (Lee & James, 2013). The intervention focused on 
cultivating self-compassion in response to PTSD symptoms (i.e., practicing a self-
compassionate response to shame and self-blame regarding the causes and consequences 
of the traumatic event). The primary study aim was to evaluate the feasibility, tolerability, 
and efficacy of this compassion-based intervention for reducing shame and PTSD 
symptoms, using a multiple baseline experimental design. Multiple baseline, a type of 
single-case experimental design, is a time- and cost-effective method for evaluating the 
efficacy of novel treatments. This design controls for spontaneous recovery over time and 
other threats to internal validity that are not controlled for in an open trial. 
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Hypotheses 
The primary hypotheses were: (1) Participants will report reductions in shame and 
PTSD symptoms, as measured by the ISS and PCL-5. These improvements will be 
maintained during the follow-up assessment period; (2) Participants will report increases 
in self-compassion, as measured by SCS. These gains will be maintained at follow-up; 
(3) Reductions in shame and PTSD symptoms will correlate with increases in self-
compassion; and (4) Participants will tolerate the intervention and report high levels of 
satisfaction, as indicated by the CEQ and protocol evaluation survey. Secondary 
hypotheses were: (1) participants will report improvements in secondary outcome 
measures, including mindfulness, self-blame, and positive and negative affect, as 
measured by the CAMS-R, PTCI-sb, and PANAS, respectively. Improvements will also 
be maintained during the follow-up assessment period; (2) Greater homework compliance 
will correlate with greater gains in outcome measures; (3) Improvements in secondary 
outcome measures will correlate with changes in self-compassion. 
 
METHODS 
Participants 
Participants consisted of 10 individuals who had experienced a potentially 
traumatic event and reported elevated posttraumatic shame and PTSD symptoms. 
Inclusion criteria were: (1) a least 18 years of age; (2) exposure to a traumatic event, as 
defined by DSM-5 PTSD Criterion A, at least 1 month prior to the screening; (3) elevated 
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PTSD symptoms (total score ≥ 27 on the PTSD Checklist [PCL-5]); (4) elevated shame 
related to the traumatic event (total score > 40 on the Internalized Shame Scale [ISS]); (5) 
normative levels of shame before the traumatic event (estimated ISS before the trauma ≤ 
40 and at least 10 points lower than current ISS); (6) if taking psychotropic medication, 
stabilized dose for a minimum period of at least 8 weeks; and (7) ability to complete 
study procedures. Exclusion criteria were: (1) elevated current risk that would indicate 
need for a higher level of care, including current suicidal ideation and intent, 
endorsement of screening items suggesting psychotic or bipolar disorder, or current or 
recent (within 3 months) history of substance use disorder (not including caffeine, 
nicotine, or cannabis use disorder); and (2) concurrent psychotherapy for trauma-related 
problems.  
Participant characteristics are presented in Table 1. Nine of 10 participants had 
experienced at least one other traumatic event in addition to the index trauma, which each 
participant identified as the traumatic event that resulted in the most shame, self-blame, 
and self-criticism. Two participants were on a stabilized dose of antidepressants for over 
one year before enrollment in the study. Three participants had been engaged in 
supportive psychotherapy prior to their enrollment in this study and were allowed to 
continue with this therapy, since the participants and the outside therapists agreed to 
focus the supportive therapy on general life stressors (e.g., relationship issues) and not to 
focus on the trauma for the duration of their participation in the study.  
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Study Design 
To evaluate the efficacy of the intervention for reducing shame and PTSD 
symptoms, a multiple baseline design was used (Barlow et al., 2009). Participants were 
randomly assigned to a 2-, 4-, or 6-week baseline assessment phase, which entailed 
completing self-report questionnaires each week. They continued to complete weekly 
questionnaires during the 6-week treatment phase and twice over a 4-week post-treatment 
phase. Randomizing participants to baseline periods of varying lengths enables 
assessment of whether changes in PTSD symptoms and shame occur when and only 
when the intervention is applied. If changes do not occur during the baseline period 
(regardless of its duration) and instead occur only once the intervention is applied, this 
suggests that the changes are due to the intervention and not other factors, such as the 
passage of time, the repeated nature of assessments, or historical events. This design 
therefore allows causal inferences to be made, and since each participant acts as their 
own control, fewer participants are needed to demonstrate change as a result of the 
intervention. In addition, the frequent assessments allow for evaluation of symptom 
change stability and intra-subject variability, and for detection of symptom change 
relative to the introduction of specific treatment components. 
 
Procedures 
Participants were recruited from the community via flyers posted on community 
bulletin boards and internet paid research study postings. Interested individuals 
completed a brief online screen, consisting of self-report questionnaires to assess 
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inclusion and exclusion criteria. Those who appeared to be eligible were invited for an in-
person assessment, where the investigator obtained informed consent, administered 
assessment procedures, and described the study procedures. The assessment included 
additional self-report questionnaires and a 30-minute interview. To ensure that the shame 
reported was linked to the traumatic event experienced, participants were asked to 
complete the ISS first in reference to the past month, and then in reference to the period 
before the traumatic event. Participants were then interviewed to assess the impact of the 
trauma on their self-perception. These procedures were used because we sought to 
evaluate the effect of a compassion intervention on trauma-related shame, not life-long 
shame potentially attributable to other causes. Individuals who did not meet 
inclusion/exclusion criteria after the screening or in-person assessment were provided 
with a list of alternative treatment referrals within the community.   
After enrollment in the study, participants were randomized to a 2-, 4-, or 6-week 
baseline assessment period. They completed a weekly self-report assessment battery 
throughout the baseline period. The modal period of time between assessments during the 
baseline phase was 1 week. During the treatment phase, all participants received six 
weekly, 60-90 minute individual sessions of compassion-based therapy. They were 
required to complete the weekly assessment battery one week after each treatment session, 
before proceeding with the next treatment session. The modal time between treatment 
sessions was 1 week, with a maximum of 2 weeks between sessions due to scheduling 
conflicts and weather. During the post-treatment phase, participants completed the 
weekly assessment battery 1 week, 2 weeks, and 4 weeks after the final treatment session. 
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All self-report questionnaires in this study were completed online using Qualtrics, a 
secure, confidential Internet-based survey program widely used for data collection.  
The therapist who conducted all in-person assessments and treatment sessions was 
the lead investigator of this study (TMA), who was a Master’s-level clinician in an APA-
approved doctoral program in Clinical Psychology at the time the study was conducted. 
At the end of their participation in the study, participants received a small monetary 
compensation. All procedures were approved by the Boston University Institutional 
Review Board. 
Participant flow is presented in Figure 1. One advantage of a multiple baseline 
design is that the baseline phase can be used to exclude participants who spontaneously 
recover on their own over time. Two participants were withdrawn after they experienced 
immediate PTSD symptom reduction (PCL-5<27) after attending the in-person 
assessment. These reductions were sustained over the course of five weeks during the 
baseline phase.  
Two participants dropped out after completing all of their baseline assessments 
but before starting treatment. One participant dropped out after completing a 6-week 
baseline phase, stating that she no longer wished to address her trauma and found it too 
stressful to fill out the weekly questionnaires. During the baseline phase, her self-report 
data indicated a reliable reduction in shame severity over the course of six baseline 
assessments but not in PTSD symptom severity. The other participant dropped out after 
completing the 2-week baseline because she anticipated she would be too busy to 
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participate in the treatment. Her data did not indicate a reliable change in either PTSD or 
shame severity during baseline.  
Three participants dropped out during treatment. One of these participants was 
withdrawn from the study after Session 2 when she did not respond to multiple attempts 
to contact her to schedule the next treatment session. Her data after Session 1 indicated 
that her PTSD and shame severity had decreased slightly compared to baseline. Another 
participant dropped out after Session 2, citing scheduling conflicts and lack of readiness 
to think about the trauma. Her PTSD and shame severity after Session 1 had not yet 
reliably changed from baseline. The third participant dropped out after Session 5 after she 
informed study staff that she was feeling emotionally overwhelmed and decided to seek 
inpatient hospitalization instead of continuing with the study. This participant’s PTSD 
and shame severity scores increased slightly from baseline to Session 4, but this increase 
was not reliable. The extent to which the intervention may have contributed to symptom 
exacerbation in this participant is unclear, since she did not complete the Session 5 
assessment battery and did not provide further details about the nature of her 
hospitalization.  
Compared to treatment completers, the five participants who dropped out did not 
have discernable differences in terms of demographics, time since trauma, type of trauma, 
or symptom severity. In single-case experimental design, participants act as their own 
controls. Non-completers therefore were not included in the final analyses, since they 
lacked sufficient data. 
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Intervention 
Table 2 summarizes the primary target and intervention components for each 
session. The first half of the intervention (Sessions 1-3) focused on building general 
mindfulness skills and self-compassion for everyday difficulties that were not trauma-
related. The second half of the intervention (Sessions 4-6) focused on directly applying 
the self-compassion skills learned in Sessions 1-3 to the index trauma. Each treatment 
session included instruction and in-session practice of various experiential exercises, 
which participants were then asked to practice on their own during the week before their 
next session. Sessions 2-6 began with a brief (5-10 minute) mindfulness or self-
compassion exercise, including mindful breathing, mindful walking, mindful eating, and 
some of the self-compassion exercises detailed below. The homework was then reviewed 
before proceeding with the new session material and experiential exercises. After the 
experiential exercises, participants shared their reactions to the exercises and made a plan 
for practicing at home. 
In Session 1, participants received general psychoeducation on PTSD symptoms 
and instruction on mindfulness. Shame and self-blame were normalized as common 
reactions to trauma, and participants received information on how these experiences can 
create an ongoing sense of internal threat that maintains PTSD symptoms. Mindfulness 
was introduced as a way to increase engagement with experience, instead of reactively 
avoiding internal or external cues that trigger shame, self-blame, and other PTSD 
symptoms. Session 1 focused first on mindfulness because mindfulness of suffering is 
often conceptualized as an essential component of self-compassion (Neff, 2003). In 
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addition, receiving some instruction on mindfulness is often considered necessary before 
beginning self-compassion work, to set the stage for using self-compassion as a way to 
open up to difficulties, rather than as an avoidance or distraction strategy (Germer & Neff, 
2014). Simple grounding techniques (i.e., orienting oneself to the present when feeling 
emotionally overwhelmed and using the five senses to increase awareness of the present) 
were practiced in session. Mindful breathing was also practiced in session as another 
technique for anchoring oneself in the present moment. 
The concept of self-compassion was not explicitly introduced until Session 2, 
which focused on introducing the idea of self-compassion and building the motivation to 
practice it. As part of the rationale for practicing self-compassion, psychoeducation was 
provided on the interactions between three emotion regulation systems: the threat/self-
protection, achievement/activating, and contentment/soothing systems (Gilbert & Procter, 
2006). Compassion was introduced as a way to regulate the threat/self-protection system, 
which is associated with emotions such as shame, fear, and sadness, and to activate the 
contentment/soothing system. Self-compassion was defined broadly, and then 
conceptualized as consisting of three parts (Neff, 2003): mindful awareness of one’s 
suffering, recognition of one’s common humanity, and responding to one’s suffering with 
kindness, warmth, and understanding. Fear of compassion was normalized, and 
participants identified any misconceptions of self-compassion that they held (e.g., “I’ll 
never get anything done if I’m too compassionate with myself,” “I don’t deserve self-
compassion,” “Self-compassion is selfish”). These misconceptions were explored with a 
vivid story adapted from Otto (2000), in which participants imagine a young child who is 
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either berated by a harshly critical “Coach A” versus treated compassionately by a 
“Coach B.” After hearing the story, participants first identified the coach they would pick 
for a child they cared about, before identifying the coach that they tend to pick for 
themselves when they have difficulties or make mistakes. The session ended with the 
“Self-Compassion Break” exercise, which entails asking participants to recall a stressful, 
non-trauma-related situation from their everyday lives, and then repeating a series of 
individualized phrases to practice the three parts of self-compassion (Neff & Germer, 
2013). For homework, participants were instructed to practice the Self-Compassion Break 
exercise and also write a compassionate letter to themselves about a current difficulty 
unrelated to the trauma. 
In Session 3, participants continued to focus on building self-compassion for 
everyday difficulties that were not directly related to the trauma. Smell was discussed as 
a sensory experience that is often strongly associated with both negative and positive 
memories and can trigger strong emotional reactions (Lee & James, 2013). Participants 
chose a scent that they liked from a selection of essential oils and then paired this scent 
with the remaining experiential exercises. The remainder of the session consisted of two 
experiential exercises for practicing self-compassion. The first exercise, “Sending 
Compassion” involved silently repeating four phrases commonly used in loving kindness 
meditation to send compassion to a loved one, repeating the phrases as they imagined 
themselves with their loved one, and finally repeating the phrases as they focused on only 
themselves (Neff & Germer, 2013). The second exercise, the “Perfect Nurturer” involved 
imagining themselves in the company of someone who epitomizes compassion (e.g., an 
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idealized historical figure, a character created purely from their imagination, a character 
from a book or film) (Lee & James, 2013; Gilbert, 2010). Participants were encouraged 
to use sensory descriptions to create a strong felt impression of their perfect nurturer (i.e., 
imagining what they would see, hear, smell, etc when in the presence of their perfect 
nurturer).  
Session 4 entailed applying the self-compassion practices from Sessions 2 and 3 
to the index trauma. Participants identified the worst moment of their trauma and 
brainstormed how they would ideally imagine their perfect nurturer comforting and 
supporting them if they showed their perfect nurturer what they had experienced (Lee & 
James, 2013). They practiced vividly imagining their perfect nurturer before showing 
their nurturer their memory of the trauma and imagining what their perfect nurturer 
would do or say to offer comfort and support. Participants also imagined how they would 
like their perfect nurturer to respond to their feelings of shame and self-blame.   
 In Session 5, participants continued to practice self-compassion in response to 
their trauma. This session involved identifying difficult trauma-related emotions such as 
shame and disgust, which typically arise when they are reminded of the trauma. They 
described their typical reaction to those difficult emotions (e.g., self-criticism, distraction) 
and were introduced to the alternative response of opening up to and accepting the 
emotion with self-compassion. Participants were introduced to the “Compassion Antidote” 
exercise, which entailed locating and visualizing the emotion in the body, mindfully 
describing the qualities of the emotion, and then softening into the emotion, allowing it to 
be there, and soothing themselves for experiencing the difficult emotion (Germer & Neff, 
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2014; Neff & Germer, 2013). The exercise ended with visualizing compassion in the 
body (Lee & James, 2013). For homework, participants practiced the “Compassion 
Antidote” exercise in addition to writing a second compassionate letter to themselves, 
using a self-compassionate approach to address the trauma they experienced and the 
difficulties they had experienced since the event. 
In the final session, Session 6, participants reviewed the self-compassion skills 
from the intervention, reflected on their progress and changes they had experienced since 
starting the intervention, and made a plan for continued self-compassion practice.  
Before enrolling participants in this study, components of the intervention were 
pilot tested with volunteers, and the entire intervention was pilot tested with one 
volunteer. Qualitative feedback from pilot testing was used to make modifications and 
adjustments to various intervention components, before the intervention was used with 
this study’s participants.   
All treatment sessions were audio recorded for supervision and adherence rating 
purposes. One recording from each participant was randomly selected to evaluate the 
therapist’s adherence to the intervention. Independent raters evaluated a total of 10 
recordings (17% of the total recordings) for adherence, using a checklist of pre-
determined goals for each session. Session adherence ratings were good, ranging from 
90%-100% (mean=98.33%, mode=100%).  
 
Measures 
On the initial online screening questionnaire, current substance use disorders were 
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assessed with the Alcohol Use Disorders Identification Test (AUDIT; Babor, Higgins-
Biddle, Saunders, & Monteiro, 2001) and Drug Abuse Screening Test (DAST-10; Skinner, 
1982), which have both demonstrated good psychometric properties. Bipolar disorder and 
psychosis were screened with the Mood Disorders Questionnaire (MDQ; Hirschfeld, 
2002) and the 5-item psychotic symptoms screen from the Psychiatric Diagnosis 
Screening Questionnaire (PDSQ; Zimmerman & Mattia, 2001), which have both 
demonstrated good sensitivity and specificity. To assess for exposure to a broad range of 
potentially traumatic events, the 23-item Traumatic Life Events Questionnaire (TLEQ; 
Kubany et al., 2000) was used. On the TLEQ, the number of times each event was 
experienced can be indicated on a 7-point scale that ranges from “never” to “more than 
five times.” The TLEQ has demonstrated good temporal stability over a 2-month interval, 
content validity, and convergent validity with a structured-interview assessment of PTE 
exposure (Kubany et al., 2000). Exposure to at least one PTE, as defined by PTSD 
Criterion A in DSM-5, was then confirmed during the in-person assessment interview. At 
the in-person assessment, the Beck Depression Inventory-II (BDI-II; Beck, Steer, & 
Brown, 1996) was used to assist in screening for current suicidal ideation. Participants 
also completed a brief demographics questionnaire to indicate their age, gender, ethnicity, 
level of education, marital status, and employment status.   
The primary outcomes of PTSD symptom severity and shame severity were 
assessed using self-report questionnaires administered as part of the online screen, in-
person assessment, and weekly assessment battery. PTSD symptom severity was assessed 
with the PTSD Checklist for DSM-5 (PCL-5; Weathers et al., 2013), a widely-used 
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measure based on the DSM-5 criteria for PTSD. Respondents indicate the degree to 
which they have been bothered by each of 20 PTSD symptoms. The PCL-5 has 
demonstrated strong psychometric properties and high quality of efficiency for predicting 
PTSD diagnosis based on the gold-standard PTSD diagnostic interview, the Clinician-
Administered PTSD Scale for DSM-5 (Bovin et al., under review). Test-retest reliability 
was .86 for a 1-month interval (Bovin et al., under review). Total score on the PCL-5 
ranges from 0 to 80, and 10-20 point changes are generally considered clinically 
significant. The PCL-5 can also be scored to provide a provisional PTSD diagnosis. 
Shame was measured with the 24-item shame subscale of the Internalized Shame 
Scale (ISS; Cook, 2001; Wong & Cook, 1992). Shame items were derived from 
phenomenological descriptions of the shame experience (e.g., “I feel like I am never quite 
good enough,” “I feel as if I am somehow defective as a person, like there is something 
wrong with me”). Respondents use a 5-point Likert-type scale to indicate the frequency 
of each shame experience. The ISS has demonstrated good psychometric properties, 
including high concurrent validity, internal consistency, and test-retest reliability (r=.94 
with a 5-week interval; Goss, Gilbert, & Allan, 1994; Cook, 2001). Total scores on the 
shame subscale range from 0 to 96.  
The PCL-5 and ISS were anchored to the “past month” on the online screen and 
in-person assessment, and to the “past week” for the weekly assessment battery 
administered during baseline, treatment, and follow-up. The following self-report 
questionnaires were administered as part of the weekly assessment battery and were 
anchored to the “past week”: 
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Self-compassion was measured with the 26-item Self-Compassion Scale (SCS; 
Neff, 2003). The SCS assesses the positive and negative aspects of the three main 
components of self-compassion, yielding six subscales: self-kindness, self-judgment, 
common humanity, isolation, mindfulness, and over-identification. Respondents rate each 
item using a 5-point Likert-type scale, ranging from 1 = “almost never” to 5 = “almost 
always.” The SCS has demonstrated strong psychometric properties, including good test-
retest reliability over a 3-week interval (r=.93; Neff, 2003). Subscale scores were 
calculated by taking a mean of the subscale items, and the six subscales were then 
averaged to calculate a total SCS score. Subscale and total scores therefore range from 1 
to 5. 
Self-blame was assessed with the 6-item self-blame subscale of the Posttraumatic 
Cognitions Inventory (PTCI-sb; Foa, Ehlers, Clark, Tolin, & Orsillo, 1999). Respondents 
rate the extent to which they agree or disagree with six statements (e.g., “The event 
happened because of the way I acted”), using a 7-point Likert-type scale, from 1 = 
“totally disagree,” 4 = “neutral,” and 7 = “totally agree.” This subscale has demonstrated 
good internal consistency, convergent validity, discriminant validity, and test-retest 
reliability with a 1-week interval (r=.89, Foa et al., 1999). The subscale score is the mean 
of the six items; scores range from 1 to 7.   
Positive and negative affect were measured with the 20-item Positive and 
Negative Affect Scale (PANAS; Watson, Clark, & Tellegen, 1998). The PANAS consists 
of a 10-item positive affect (PA) scale and 10-item negative affect (NA) scale, which 
have demonstrated good convergent and discriminant validity. The two scales are largely 
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uncorrelated, internally consistent, and reliable over a 1-week interval (test-retest r=.79 
for PA, r=.81 for NA; Watson et al., 1998). Total scores on each scale range from 10 to 
50. 
Mindfulness (i.e., present moment attention, awareness, and acceptance) was 
measured with the 12-item Cognitive and Affective Mindfulness Scale-Revised (CAMS-
R; Feldman, Hayes, Kumar, Greeson, & Laurenceau, 2007). The CAMS-R has 
demonstrated good internal consistency, convergent validity, and discriminant validity. 
The CAMS-R can be used as a pre-post measure of change in mindfulness (Greeson et al., 
2011; Neff & Germer, 2013) and is particularly useful for clinical studies, since it 
correlates more strongly with psychological distress (e.g., psychological symptoms, 
neuroticism, and difficulties in emotion regulation) than other measures of mindfulness 
(Baer et al., 2006). Total scores on the CAMS-R range from 12 to 48.  
As part of the weekly assessment battery, participants completed the 
Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000), which 
measures cognitively-based treatment credibility and affectively-based treatment 
expectancy. The three credibility items of the CEQ ask participants to rate how logical 
the therapy seemed, how successful it was in treating their symptoms, and their 
confidence in recommending the therapy to a friend. These items were rated on a scale of 
1 to 9 (1 = “not at all,” 5 = “somewhat”, and 9= “very”). A credibility subscale score was 
calculated using the mean of these three items, with scores ranging from 1 to 9.  
Participants completed a weekly homework compliance questionnaire to indicate 
the number of times they practiced the skills learned in the previous session over the past 
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week and to rate the helpfulness of each skill. After each session, the study therapist also 
rated the participant’s homework compliance and quality. One week after the final 
treatment session, in addition to the regular assessment battery, participants completed a 
Protocol Evaluation Survey to evaluate the intervention and provide qualitative feedback 
and recommendations for improving the intervention. A list of the intervention 
components (e.g. mindful breathing, compassionate letter writing) was provided, and 
participants were asked to use a 5-point Likert-type scale to rate the extent to which they 
found each component helpful.  
 
Data Analysis 
Data analyses were conducted according to established guidelines for analyzing 
data from single-case experimental designs (Barlow et al., 2009; Kazdin, 2011). For 
single-case designs, visual inspection is the primary method used to describe the data and 
make inferences about the reliability of changes. It entails visually examining the graphed 
data within-subjects and between-subjects to evaluate the magnitude and rate of change 
across phases. Changes in mean and level (i.e., a shift from the end of one phase to 
another) across phases indicate the magnitude of the treatment effect, while the latency of 
change and changes of slope indicate the rate of change. The overall pattern can also be 
evaluated by examining whether the data overlap across phases (e.g., whether scores 
during the treatment phase overlap with the range of scores observed during the baseline 
phase). Visual inspection is often considered a more conservative approach than using 
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statistical tests, since visual inspection relies on very potent and consistent effects that are 
readily seen (Kazdin, 2011).  
In this study, data from the PCL-5, ISS, PTCI-sb, and SCS were plotted 
graphically for each participant. The effect of treatment was evaluated for each 
participant by comparing the level, mean, and slope of outcome variables during the 
treatment phase, against their baseline phase. Between-subjects comparisons were made 
by comparing the level, mean, and slope of outcome variables in the treatment phase 
against the baseline phases of participants who remained in the baseline phase and had 
not yet begun treatment. Symptom change was also evaluated in relation to specific 
treatment components that were introduced at different times. Specifically, changes in 
level between Sessions 1 and 2 were evaluated to assess the differential impact of 
psychoeducation and mindfulness versus self-compassion, since self-compassion was not 
introduced until Session 2. Also, changes in level between Sessions 3 and 4 were 
examined to evaluate the effect of directly applying self-compassion skills to the trauma 
in Session 4, compared to practicing self-compassion skills for general, everyday life 
difficulties in Session 3.  
For each participant, change scores were calculated as follows: 1) baseline change 
= last baseline score before starting treatment - first baseline score, 2) pre-post change = 
score after treatment session 6 - last baseline score before starting treatment, and 3) pre-
follow-up (pre-FU) change = 4-wk follow-up score - last baseline score before starting 
treatment. To supplement visual inspection, 95% confidence intervals were calculated for 
each participant’s change scores to evaluate the reliability of the change. For each 
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measure, a standard error of the difference (Sdiff) was calculated, following the method 
developed by Jacobson and Truax (1991) for calculating reliable change:  
Sdiff  =    2(SE)2 , where SE = SD   1 – rxx   
SD = the standard deviation of the measure taken from published data (i.e., normative 
data or a large clinical sample), and rxx= the test-retest reliability coefficient taken from 
published data. It is also possible to use the pre-treatment SD from the study sample, but 
given the small sample size of this study, using the SD and rxx from larger samples in 
published psychometrics studies yielded a more stringent and conservative Sdiff. The 
resulting Sdiff represents the difference between scores (i.e., change score) that would be 
expected by chance variation alone on a specific measure. For example, on the PCL-5, 
based on a clinical sample of trauma-exposed individuals where SD=21.16 and 1-month 
test-retest r=.86 (Bovin et al., under review), Sdiff = 11.20, indicating that an individual’s 
PCL-5 test-retest scores at a 1-month interval are likely to deviate by 11.20 points on 
average, from chance variation alone.  
A separate Sdiff was calculated for each measure, using SDs and test-retest 
reliability coefficients from published data (Bovin et al., under review; Cook, 2001; Goss 
et al., 1994; Foa et al., 1999; Neff, 2003; Watson et al., 1988). When available, data from 
clinical populations were used to calculate Sdiff . No known studies of the CAMS-R have 
evaluated test-retest reliability (G. Feldman, personal communication, June 25, 2015). A 
test-retest reliability coefficient from the present study’s Baseline 1 and Baseline 2 
assessments was calculated (r=.80, n=10). However, the alpha coefficient from a 
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published study (α=.76; Feldman et al., 2007) was used instead, since it was derived from 
a larger sample and provided a slightly more conservative estimate of Sdiff. 
The Sdiff for each outcome variable are as follows: PCL-5 Sdiff = 11.20, ISS Sdiff = 
7.27, PTCI-sb Sdiff = .82, SCS Sdiff = .23, CAMS-R Sdiff = 4.86, PA Sdiff  = 4.86, NA Sdiff  = 
5.67. For each measure, Sdiff was multiplied by 1.96 to create a 95% confidence interval 
(CI) around each change score. For example, on the PCL-5, 1.96 X Sdiff = 21.95. For a 
given participant, the change score between two timepoints was calculated, as well as a 
95% CI 21.95 points above and below the change score. We can be 95% confident that 
the true amount of change for each participant falls within 21.95 points above and below 
the observed change score. For example, if a participant’s PCL-5 pre-post change score 
was -30 (i.e., score decreased by 30 points), the confidence interval would be -30 ± 21.95. 
That is, we can have 95% confidence that the true change the participant experienced was 
between -51.95 to -8.05. Since this CI does not include zero, the observed change score 
can be considered statistically non-zero at p < .05 (i.e., there is a statistically significant 
change). Correlations between change scores were also performed to test the hypothesis 
that reductions in shame and PTSD symptoms are related to changes in self-compassion.  
An overall, standardized mean difference for each outcome variable was also 
calculated, using a d-statistic specifically developed for single-case designs, including 
multiple baseline (Shadish, Hedges, & Pustejobsky, 2014). As reviewed by Shadish et al. 
(2014), other d-statistics (e.g., Cohen’s d) were developed for between-subjects designs, 
such as randomized controlled trials, and cannot be readily applied to within-subjects 
designs. Shadish et al. developed a d-statistic for single-case experimental designs that 
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takes into account autocorrelation, between and within-case variance, and corrects for 
small sample bias using Hedges’ g. The resulting d-statistic is in the same metric as the d-
statistic used in between-subjects designs and can be used in meta-analysis that includes 
both between-subjects designs and single-case designs. The d-statistic was calculated 
using the DHPS SPSS macro available on the developer’s website (Shadish, 2015), and 
the calculated variance was used to calculate 95% confidence intervals for each outcome 
variable: d ± 1.96 X   Var. The effect size was considered statistically significant at p 
< .05 if the 95% confidence interval did not include zero. It is important to note that 
Shadish et al.’s d-statistic utilizes a mean across all baseline observations, a mean across 
all treatment observations (i.e., across all six treatment sessions), and a mean for the two 
follow-up observations. It does not take into account the slope of change during the 
treatment phase. For gradual improvements that occur over the course of the six treatment 
sessions, the d-statistic calculated from baseline to follow-up may be more representative 
of the intervention effect than the d-statistic calculated from baseline to treatment. 
To determine acceptability and feasibility of the intervention, retention rates, data 
from the CEQ, participants’ satisfaction ratings of the intervention, and qualitative 
feedback were examined.  
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RESULTS 
Shame and PTSD Symptom Severity 
At the initial in-person assessment, all 10 participants met the diagnostic criteria 
for PTSD, based on self-report, with total scores on the PCL-5 suggesting moderate to 
severe PTSD symptom severity (M = 47.90, SD = 9.05, range 36 to 61). Fig. 2 displays 
PCL-5 and ISS scores across 2-, 4-, and 6-week baseline assessments (B1 through B6), 
after each of the six treatment sessions (T1 through T6), and 2-week and 4-week follow-
up (F1 and F2). Individual graphs in Fig. 2 were arranged in three columns, with the first 
column containing a 2-week, a 4-week, and a 6-week baseline, and the following two 
columns serving as replications. Within this layout, individual graphs were arranged in 
the order in which participants (P1 to P10) were enrolled in the study. Table 3 presents 
the change scores with 95% CIs for each participant during baseline (B1 to last baseline 
assessment), treatment (last baseline to T6), and follow-up (last baseline to F2). Table 3 
also lists the 1.96 X Sdiff value used for each measure to calculate the confidence intervals 
around each change score. 
Visual inspection of baseline data in Fig. 2 suggests that baseline PTSD and 
shame severity scores were either stable or increasing for all participants. The 95% CIs 
for the change scores from B1 to the last baseline (see Table 3) confirm that during 
baseline, there were no reliable changes on the PCL-5 for any participants, while five 
participants demonstrated reliable increases in shame on the ISS. Some participants 
demonstrated temporary decreases on the PCL-5 and ISS during baseline (e.g., for P6, 
PCL-5 and ISS scores sharply decreased at B3 while he was on vacation). However, these 
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decreases were transient and not reliable (i.e., not statistically significant at p<.05) 
because they did not exceed the 1.96 X Sdiff value on the PCL-5 or ISS. One participant 
(P5) demonstrated at B1 a 20-point decrease on the PCL-5 and a 39-point drop on the 
ISS, relative to her PCL-5 (past month) score of 36 and ISS (past month) score of 75 at 
the in-person assessment (not graphed). However, her PCL-5 and ISS scores rebounded 
and stabilized between B2 and B4, suggesting that the decrease at B1 after attending the 
in-person assessment was transient. The stability seen during baseline for most 
participants suggests that there were no reliable improvements in PTSD and shame 
severity due to repeated assessments, the passage of time, or chance variation in scores, 
and that shame worsened with time for many participants. 
Treatment phase data in Fig. 2 indicate decreases in PTSD symptom severity for 9 
of 10 participants and decreases in shame for 8 participants. The 95% CIs for the change 
scores from the last baseline to post-treatment (T6) (see Table 3) indicate that these 
reductions were reliable, with the exception of P5, whose decrease on the PCL-5 was not 
reliable until follow-up. P5’s PCL-5 and ISS treatment scores overlapped with her 
baseline scores due to the transient decrease she demonstrated at B1, but her baseline 
PCL-5 and ISS scores had a positive (increasing) slope, while her treatment scores had a 
steep negative (decreasing) slope. P3 did not show reliable reductions on the PCL-5 or 
ISS, and P3’s treatment scores on both measures overlapped entirely with baseline scores. 
P9 showed reliable reductions on the PCL-5 but not the ISS. P9’s post-test PCL-5 and 
ISS scores did not overlap with her baseline scores, but the magnitude of the change on 
the ISS was too small to be statistically significant. Overall, participants showed large 
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reductions on the PCL-5 and ISS during the treatment phase, with an average PCL-5 
change of -27.30 (SD = 14.96, range 0 to -52) and an average ISS change of -36.50 (SD = 
20.51, range -1 to -62). The negative slope of PCL-5 and ISS scores during the treatment 
phase, compared to the stable or increasing trends seen at baseline, suggest that these 
reductions may be due to the intervention, rather than time or self-monitoring. At post-
treatment (by T6), all 10 participants no longer met PTSD diagnostic criteria based on the 
PCL-5, including P3. 
Follow-up data in Fig. 2 suggest that treatment gains on the PCL-5 and ISS were 
maintained during the 4-week follow-up phase. By 4-week follow-up, P5’s PCL-5 and 
ISS scores did not share any overlap with her baseline scores. P3 did not show reductions 
on the PCL-5 or ISS during treatment but demonstrated a 15-point decrease on the PCL-5 
at follow-up. Although this decrease was not reliable, P3’s PCL-5 scores of 14 and 17 at 
2- and 4-week follow-up suggest minimal PTSD symptoms and do not overlap with any 
baseline scores. P3 also showed a statistically significant decrease on the ISS from the 
last baseline to 4-week follow-up. However, since visual inspection of Fig. 2 indicates 
that P3’s follow-up ISS scores overlap completely with the highly variable baseline 
scores, the degree of change from pre-FU was unclear, and this change was not 
considered evidence of treatment response. P9’s PCL-5 and ISS scores at follow-up do 
not overlap with her baseline scores, but the change from last baseline to 4-week follow-
up was not large enough to be reliable. Across all participants, the mean change from the 
last baseline to 4-week follow-up was -31.40 (SD = 14.18, range -12 to -58) on the PCL-5 
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and -40.40 (SD = 19.76, range -9 to -66) on the ISS. At 4-week follow-up, none of the 
participants met the diagnostic criteria for PTSD, based on the PCL-5. 
 
Secondary Outcomes: Self-Blame, Self-Compassion, Mindfulness, Positive and 
Negative Affect 
Self-blame and self-compassion scores for each participant are graphically 
displayed in Fig. 3. Visual inspection suggests that self-blame scores on the PTCI-sb 
follow a similar pattern to PCL-5 and ISS scores; stable baselines are followed by reliable 
decreases for all participants except for P9, whose self-blame scores during treatment 
overlapped entirely with her baseline scores. These reductions were reliable (see Table 
4), except for P7 whose decrease in self-blame was not quite reliable. However, P7’s self-
blame scores at post-test and follow-up did not overlap with any of her baseline scores. 
Of note, P3 did not demonstrate reliable decreases on the PCL-5 and ISS during 
treatment but showed reliable decreases in self-blame, with treatment and follow-up 
scores that did not overlap with baseline scores. All participants who showed reductions 
in self-blame during treatment maintained these gains at follow-up. 
 Self-compassion scores on the SCS were stable or worsening at baseline for all 
participants, except for P10 who demonstrated a small but reliable increase in self-
compassion at baseline (see Table 4). P10 reported that filling out the baseline 
questionnaires had increased her awareness of her tendency towards self-criticism and 
that this had motivated her to be kinder towards herself. During the treatment phase, all 
participants except for P3 showed increases in self-compassion, with an average change 
score of 1.53 on the SCS (SD = .98, range .15 to 3.12). P10 demonstrated a larger and 
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steeper increase in self-compassion during treatment, relative to the small increase seen at 
baseline. Overall, these data suggest that the intervention was effective in increasing self-
compassion. These gains were maintained at follow-up, where 9 participants 
demonstrated increases in self-compassion relative to their last baseline score. However, 
P3’s increase in self-compassion from last baseline to 4-week follow-up, although 
statistically significant, is much less apparent via visual inspection than for other 
participants, and P3’s follow-up scores overlap entirely with the baseline scores (see Fig. 
3). 
 On other secondary outcomes, including mindfulness and positive and negative 
affect, several participants demonstrated improvements during treatment after a stable 
baseline (see Table 5). Four participants demonstrated reliable increases in mindfulness 
during treatment. By 4-week follow-up, eight participants had shown reliable increases in 
mindfulness. In terms of positive affect, three participants showed reliable increases 
during treatment and five participants showed increases at follow-up. Seven participants 
showed reliable decreases in negative affect during treatment, and eight participants had 
reliable decreases by follow-up. At follow-up, P3 showed reliable improvements in 
mindfulness, positive affect, and negative affect. 
 
Effect Sizes 
Standardized mean differences were calculated to estimate the overall magnitude 
of the intervention effect across participants, and to facilitate comparison of different 
measures. Table 6 presents the means and standard deviations for all outcome variables 
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across each study phase, as well as the standardized mean differences (d with 95% CIs) 
comparing treatment vs baseline and follow-up vs baseline. These effect sizes suggest 
that across participants, the self-compassion intervention was associated with large 
decreases in PTSD symptom severity, shame, self-blame, and negative affect, large 
increases in self-compassion and mindfulness, and a moderate to large increase in 
positive affect. Effect sizes comparing baseline vs follow-up were larger for all outcome 
variables than those comparing baseline vs treatment. The baseline vs follow-up effect 
size may be a more accurate representation of the treatment effect, since the procedure 
used to calculate d calculates a baseline mean, a treatment mean, and a follow-up mean 
and does not account for the slope during the treatment phase (Shadish et al., 2014). 
Examination of the effect sizes for the six self-compassion subscales suggests 
improvements on all six subscales, with the largest improvements seen on the self-
kindness subscale.  
 
Patterns of Symptom Change 
Several patterns of symptom change during the treatment phase are apparent in 
Fig. 2. Six participants (P1, P2, P5, P6, P8, P10) experienced small increases or relative 
stability on the PCL-5 and/or the ISS at T1, followed by sharp reductions (i.e., a steeper 
negative slope) beginning at T2, after the concept of self-compassion is introduced at 
Session 2.  
Four participants (P1, P2, P4, P5) showed the greatest PCL-5 and ISS reductions 
during the first three treatment sessions where general mindfulness and self-compassion 
  39 
skills are applied to everyday difficulties. At T4, after the self-compassion skills are 
practiced while recalling the trauma memory in Session 4, several participants’ scores on 
the PCL-5 plateaued (P1, P5) or increased for one week (P2, P4) before decreasing again 
at a slightly slower rate. On the ISS, several participants (P1, P5, P8) also showed 
transient increases in shame at Session 4 or 5, before their scores decreased again, albeit 
with a more moderate slope relative to Sessions 1 to 3. P7 showed a similar, striking 
increase on the PCL-5 and ISS at T2, after she reported at Session 2 that she had already 
begun practicing one of the self-compassion skills (i.e., writing the self-compassionate 
letter) in relation to her trauma, despite explicit instructions to complete this assignment 
only for difficulties not directly related to the trauma. In contrast, three participants (P6, 
P8, P10) demonstrated gradual decreases over the course of all six sessions, and one 
participant (P9) did not demonstrate clear reductions on the PCL-5 until after Session 4.  
Greater increases in self-compassion during treatment (from the last baseline to 
T6) were correlated with greater reductions in PTSD symptom severity (r = -.74, p<.05), 
shame (r = -.76, p<.01), self-blame (r = -.78, p<.01), and negative affect (r = -.70, p<.05). 
Change in SCS was not significantly correlated with change in positive affect (r =.63, ns). 
The same pattern was observed for changes from baseline to follow-up, with greater 
improvements on the SCS correlating with larger decreases in PTSD symptom severity (r 
= -.76, p<.05), shame (r = -.79, p<.01), self-blame (r = -.78, p<.01), and negative affect (r 
= -.70, p<.05), but not positive affect (r =.56, ns). 
Therapist ratings of homework completion quality were positively correlated with 
greater reductions in PTSD symptom severity during treatment (r = -.70, p<.05).  
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Homework completion was high, with an average compliance rating of 4.9 out of 6 (SD 
= .63) and an average homework quality rating of 4.11 out of 6 (SD = 1.00).  No other 
significant correlations were observed between homework completion or homework 
compliance and changes in other outcome variables. 
 
Satisfaction with Treatment 
After completing the intervention, participants provided feedback on the 
intervention. Scores on the credibility subscale of the CEQ indicate that participants 
found the intervention highly credible (M = 7.3 out of 9, SD = 1.16). Most participants 
found that six weeks of treatment was “somewhat too little” (60%) or “far too little” 
(10%), while 20% found it to be “just the right amount” and 10% found it “somewhat too 
much.” Participants rated the treatment as “somewhat interesting” (40%) to “extremely 
interesting” (60%). Most participants (90%) found the treatment “just the right level,” 
while one participant (10%) found it “far too basic.” Participant ratings of the perceived 
helpfulness of individual treatment components was high; on average, all treatment 
components were deemed helpful (mean rating across treatment components = 3.76 out 
of 5, range 3.30 to 4.30). 
 
Quality of Life 
On the Protocol Evaluation Survey, participants rated the extent to which the 
treatment positively impacted their quality of life, with 20% responding “moderately,” 
60% “quite a bit,” and 20% “extremely.” Participants also provided qualitative feedback 
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on some of the changes they had noticed as a result of the intervention. Some common 
themes from this qualitative data: greater capacity to sit with discomfort (P1, P2, P8); 
improved relationships, including feeling more connected to others and engaging in more 
social activities (P1, P4, P5, P7, P8); improvements in self-care (P1, P3, P6, P8); greater 
comfort with and enjoyment of sexual intimacy (P2, P4); and greater enjoyment of 
activities generally (P1, P4). 
 
 
DISCUSSION 
In this study, we used a multiple baseline design to evaluate a 6-week self-
compassion intervention developed for reducing trauma-related shame and PTSD 
symptoms. Weekly pre-treatment assessments across 2-, 4-, and 6-week baseline periods 
indicated that PTSD symptoms and shame remained stable or increased, irrespective of 
the length of baseline. After the intervention began, 9 of 10 participants demonstrated 
marked, reliable reductions in PTSD symptoms and 8 participants showed reliable 
decreases in shame, relative to their scores at baseline. For 9 of 10 participants, self-
blame decreased and self-compassion increased. These increases in self-compassion 
suggest that it is feasible for trauma survivors with low baseline levels of self-compassion 
to increase in self-compassion over a relatively brief period. Treatment gains were 
maintained at 4-week follow-up. The stable baselines, rapid decrease in symptoms only 
after the intervention was introduced, and the magnitude of the changes suggest that the 
intervention effect is not likely due to chance fluctuations, regression to the mean, 
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spontaneous recovery, or the passage of time. Effect sizes comparing baseline versus 
follow-up indicated large reductions in PTSD symptoms and shame, as well as large 
improvements in the secondary outcomes of self-blame, self-compassion, mindfulness, 
negative affect, and positive affect. Participants also reported high levels of satisfaction 
with the intervention. 
Two of 10 participants had a mixed response to the intervention. One participant 
(P9) showed reliable, marked decreases in PTSD symptoms during treatment but not in 
shame. It is possible that the intervention is not as effective for the type of trauma 
experienced by P9: learning about the suicide of one of her parents, which was 
accompanied by chronic, complex feelings of loss and emptiness. The nature of this 
trauma was quite different from the other participants, the majority of whom had 
experienced sexual assault. Another participant (P3) did not demonstrate a clear response 
to the intervention in terms of PTSD symptoms or shame. P3 also did not show clear 
increases in self-compassion, which may explain the lack of change in shame. However, 
P3 showed marked and reliable decreases in self-blame during the intervention. By 
follow-up, P3 no longer met criteria for PTSD and showed reliable improvements in 
mindfulness and positive and negative affect. At follow-up, P3 reported an increase in 
life stress towards the end of treatment and through the follow-up period, and explained 
that general distress and anxiety during that time were prominent even as trauma-related 
distress decreased. Consistent with this feedback, P3’s PCL-5 responses at follow-up 
suggested more general distress than trauma-specific distress; P3’s remaining PTSD 
symptoms clustered around PTSD Criteria D and E (e.g., sleep and concentration 
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difficulties, anhedonia), which overlap considerably with depression and anxiety 
symptoms. At follow-up, P3 indicated a preference for a more general intervention, rather 
than one focused on trauma. Additional research is needed to investigate the utility of the 
self-compassion intervention for addressing comorbidities and to explore whether to 
adapt or suspend it when new life-stressors arise during treatment. 
The patterns of symptom change observed in this study suggest differential effects 
of specific treatment components. Most participants experienced minimal change in 
PTSD symptoms and shame after receiving psychoeducation and instruction on 
mindfulness in Session 1, followed by a much steeper rate of change after Session 2, 
when self-compassion is introduced. This pattern is consistent with the possibility that 
self-compassion may be mediating changes in shame and PTSD. Also consistent with this 
notion, greater increases in self-compassion were correlated with greater decreases in 
shame and PTSD. Mindfulness also increased during the intervention phase, but these 
improvements were less consistent across participants than the improvements in self-
compassion. Future studies evaluating mediation are needed to better understand the 
respective contributions of self-compassion and mindfulness to reducing shame and 
PTSD. We included a mindfulness component in this intervention on the theoretical basis 
that mindfulness facilitates self-compassion, but this should be studied further.  
Another notable pattern of symptom change was that for many participants, the 
majority of symptom change occurred in the first three sessions. Some participants also 
demonstrated temporary increases in shame and PTSD symptoms after Session 4, when 
the focus shifts from general self-compassion skills to applying those skills directly to the 
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trauma. While these increases were transient, the rate of improvement decreased slightly 
for some participants even after their scores began to decrease again. This pattern 
suggests that building self-compassion for everyday difficulties may be effective for 
reducing PTSD symptoms and trauma-related shame, even without deliberately recalling 
the trauma memory. This is an area that warrants further exploration, since many 
individuals who have experienced trauma are reluctant to engage in treatments that focus 
on the trauma but may be more willing to learn more general, broadly-applicable coping 
skills. Of the five participants who dropped out before or during the intervention, two 
dropped out due to lack of readiness to address their trauma, and one dropped out and 
sought hospitalization after Session 5, after reporting increased distress. For some 
individuals, focusing on self-compassion skills training with no trauma-memory 
processing could potentially be more tolerable. It is generally thought that activating the 
trauma memory is necessary for practicing a new, more adaptive response (Brewin et al., 
2010), but the extent to which this needs to occur when shame is present is unclear. There 
is also some evidence that practicing general coping skills is associated with reductions in 
PTSD symptoms (e.g., Kearney et al., 2013), suggesting that individuals may generalize 
those skills to their trauma without needing to explicitly evoke the trauma memory. 
Indeed, the major clinical trials that have compared TF-CBT with non-trauma focused 
therapies have been equivocal (Steenkamp, Litz, Hoge, & Marmar, in press). 
Nevertheless, future studies should evaluate the differential efficacy and retention rates 
associated with practicing self-compassion more generally versus explicitly applying 
self-compassion skills to the trauma. 
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Overall, participants tolerated the intervention well and reported high levels of 
satisfaction. Compliance with the between-session assignments (i.e., practicing self-
compassion exercises) was high. Of participants who started the intervention, 77% 
completed it. This retention rate is comparable to that of existing evidence-based 
treatments for PTSD (i.e., TF-CBT). Participants who completed the intervention 
reported that it was credible and interesting, found individual treatment components 
helpful, and provided positive qualitative feedback.  
Strengths of this study include the multiple baseline design, the brief nature of the 
intervention, and the large effect sizes across participants who had experienced multiple 
traumatic events with varying lengths of time since trauma. The study design was a cost-
effective, practical, experimental method for evaluating treatment efficacy, in which each 
participant served as their own control. Random assignment to variable baseline lengths 
and repeated assessments during the baseline period control for threats to internal 
validity, including the effect of self-monitoring via repeated assessments, the passage of 
time, regression to the mean, and historical factors (i.e., life events). The repeated 
assessments also allowed us to precisely monitor when changes occurred, strengthening 
our ability to infer that the reductions in PTSD and shame seen during the treatment 
phase were due to the intervention since these changes did not occur until the intervention 
was introduced. In addition, the repeated assessments provided preliminary information 
on the immediate effects of specific treatment components. The person-centered, 
idiographic approach of the study design also enabled a more detailed examination of 
individual factors that may contribute to treatment response and non-response. In 
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addition, the study design allowed for preliminary exploration of whether the intervention 
would be effective for different types of trauma. While most participants identified sexual 
assault as their index trauma, two participants had a different type of trauma: one 
participant (P6) experienced shame and self-blame related to experiencing a road 
accident and having difficulty recovering from it, while another (P9) had experienced a 
parent’s suicide. This study provided preliminary evidence that the self-compassion 
intervention is potentially effective not only for sexual assault but other trauma types, 
although the mixed treatment response by P9 suggests that the intervention may not be as 
effective for certain trauma types. Overall, marked reductions in shame and PTSD 
symptoms were observed across participants who had experienced multiple traumatic 
events, including several participants who had experienced repeated sexual assault by 
intimate partners. The intervention also appeared effective across participants who varied 
greatly in terms of length of time since trauma, ranging from 2 months to 14 years. 
Another strength of the intervention was its relatively brief duration (6 weeks), which 
appeared a sufficient length of time for marked symptom change and reliable increases in 
self-compassion. These rapid increases in self-compassion occurred despite participants’ 
reports during treatment that the idea of being compassionate with themselves initially 
felt unfamiliar and difficult.  
By deliberately targeting the affective experience of shame, the intervention 
addresses a common posttraumatic reaction that can contribute to the development and 
maintenance of PTSD but is not directly addressed by existing treatments. For example, 
TF-CBT uses either exposure to produce extinction of maladaptive fear responses, and/or 
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cognitive therapy to logically challenge maladaptive cognitive appraisals of the trauma. 
Both of these approaches have been shown to be effective for over-generalization of fear 
and over-accommodated beliefs about danger. However, compassion-based therapy may 
be more effective for PTSD that is maintained not by fear but by shame. Instead of 
relying on higher-level reasoning and logic, compassion-based therapy focuses on 
creating a felt-sense of kindness, warmth, and understanding towards oneself for having 
experienced the trauma or struggling to recover from it. Responding to the trauma 
memory with self-compassion may create a new, sensory-based, experience of feeling 
comforted, soothed, and supported that competes with former sensory-based memories of 
feeling ashamed, isolated, and abandoned (Brewin et al., 1996, 2010). Learning to 
respond to the trauma memory with self-compassion may also reduce the internal threat 
(i.e., view of oneself as incapable, deserving of maltreatment) that is fueled by shame and 
harsh self-criticism, and that ultimately maintains PTSD (Ehlers & Clark, 2000). Future 
research could help clarify the mechanisms underlying compassion-based therapy and the 
relationships between shame, PTSD, and self-compassion. 
There are a number of noteworthy limitations to this study. The main limitation is 
the lack of an attention or active control condition. It is therefore possible that the 
observed intervention effect is due to non-specific effects of therapy. In addition, due to 
financial and practical constraints, a single therapist administered all of the treatment 
sessions. Consequently, it is not possible to distinguish the intervention effect from any 
therapist-specific effects. The same therapist also administered the self-report 
assessments, which could have influenced participants’ ratings. Although the Hawthorne 
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Effect, in which improvement occurs as a result of simply being observed in a study, was 
not observed during the baseline period, it is nonetheless possible that the observed 
intervention effect could be due to observer effects or demand characteristics during 
treatment. Relying on self-report measures is another limitation. Future replications 
would be strengthened by adding in diagnostic assessments by an independent assessor. 
The study is also limited in its ability to draw conclusions about its 
generalizability to diverse populations and trauma types. The participants included in this 
study were a small sample and not necessarily representative of other trauma survivors. 
Most participants were undergraduate or graduate students who were well-educated, 
relatively young, and high functioning. To comply with study procedures, access to the 
Internet and basic computer skills were required. Also, most of the participants had 
experienced sexual trauma. Additional studies are needed to evaluate the intervention 
with more diverse samples and trauma types. Since this was pilot study, elevated risk and 
comorbidities were excluded. However, elevated risk and comorbidity are often the norm 
for trauma survivors. In addition, this study deliberately recruited participants whose 
shame appeared linked to a discrete traumatic event, and to this end only screened in 
individuals who reported experiencing normative levels of shame during a period in their 
life prior to the trauma and a clear increase in shame as a result of the trauma. However, 
many traumatized individuals, especially those with extensive histories of childhood 
trauma, have chronic trauma-related shame and cannot recall a time in their lives when 
they experienced less shame. Future studies should examine the extent to which this 
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intervention would need to be lengthened or modified to address early childhood trauma 
leading to pervasive, deeply entrenched shame.  
Another study limitation was that after screening for trauma-related shame during 
enrollment procedures, the weekly shame assessment (the ISS) measured general shame, 
not trauma-specific shame. The ISS was used since there were no validated, published 
measures of trauma-related shame at the time of data collection. Using a shame measure 
explicitly linked to the trauma (e.g., the recently-developed Trauma Related Shame 
Inventory; Oktedalen et al., 2014) could be helpful for more precisely assessing trauma-
related shame and distinguishing it from shame related to other causes. 
Future research directions include conducting a randomized controlled trial 
comparing self-compassion therapy to TF-CBT with a larger and more diverse sample, 
assessing the effect of the intervention on other outcome variables, studying predictors of 
treatment response and non-response, and evaluating potential adaptations of the 
intervention. Participant feedback from the study offered some preliminary indication 
that increasing self-compassion may also improve overall quality of life. Additional 
research is needed to systematically evaluate the extent to which self-compassion leads to 
changes in quality of life, relationships, or self-care behaviors among traumatized 
individuals. There is also evidence that self-compassion interventions can lead to 
reductions in external shame (Lucre & Corten, 2012), which refers to perceiving others as 
de-valuing oneself and is considered distinct from the internalized shame measured in the 
current study. Future studies could examine the relationships between external versus 
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internal shame and PTSD, and the extent to which each may be reduced with 
compassion-based therapy.  
More research is needed to understand the variables that may influence the 
efficacy of compassion-based therapy. Fear of compassion is associated with greater 
PTSD symptom severity (Miron, Sherrill, & Orcutt, 2015) and may have contributed to 
the lack of clear treatment response in two of the current study’s participants. Future 
studies could examine fear of compassion as a predictor of treatment response and 
explore the most effective ways of overcoming resistance to self-compassion and over-
identification with self-criticism (Lawrence & Lee, 2013). Other pre-, peri-, and post-
trauma variables that may affect response to compassion-based therapy include trauma 
type and severity, the extent to which peri-traumatic shame versus fear (or other 
emotional repertoires) is more prominent, and attachment history.  
 Future studies could also examine various adaptations of the intervention, 
including its utility as an adjunct to an existing evidence-based treatment for PTSD 
versus as a standalone treatment. The brief nature of the intervention would facilitate its 
use as an adjunctive treatment. However, while six weeks appeared to be a sufficient 
length of time for symptom reduction in the current study, the most common suggestions 
from participants were to lengthen the intervention or to provide more therapist contact 
(e.g., twice weekly sessions or between-session phone check-in). Another question worth 
further exploration is whether selection of an “index trauma” on which to focus the 
treatment is necessary, or whether it may be equally efficacious to adopt a more general 
approach for individuals with histories of multiple traumas. 
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Finally, an important next step would be to compare compassion-based therapy to 
other treatments for PTSD. Although existing treatments were not specifically designed 
to target shame, there is some evidence that TF-CBT reduces shame (Murray et al., 2013; 
Oktedalen et al., 2014). Future investigations should compare compassion-based therapy 
with existing evidence-based treatments for PTSD, to evaluate which treatments are most 
effective for reducing shame and most tolerable. 
In summary, the results from this study provide preliminary evidence that 
compassion-based therapy is associated with reductions in trauma-related shame and 
PTSD symptoms. The brief nature of this treatment and the rapid improvements observed 
in this study suggest that the intervention may be promising as either a standalone 
treatment or as an adjunct to other treatments. Study results and feedback from 
participants will be used to guide future work that refines the intervention, explores 
mechanisms of change and additional outcome variables, compares the intervention 
against other treatments, and evaluates treatment efficacy on a larger-scale and for more 
diverse populations.  
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Table 1. 
Participant Characteristics 
 Age Gender Ethnicity 
Marital 
Status Education 
Employment 
Status Index Trauma 
Time since 
trauma 
Total 
PTEs 
Psychotropic 
Medications 
Concurrent 
therapy 
P1 23 female EA N Bachelor’s GS Sexual assault 5 years 5 None None 
P2 21 female EA-ME N Some 
college 
US Repeated threats 
of rape by 
intimate partner 
1.5 years >5 None None 
P3 20 non-
binary 
EA N Some 
college 
US; PT Sexual assault 4 months 3 None None 
P4 31 female PR M Bachelor’s GS Sexual assault 14 years >5 A None 
P5 19 female I N Some 
college 
US Sexual assault 2 years 4 None Supportive 
P6 32 male EA M Bachelor’s FT Hit by car while 
cycling 
2 months 3 A Supportive 
P7 20 female EA N Some 
college 
US; PT Sexual assault 3 years 2 None None 
P8 20 female EA N Some 
college 
US Repeated sexual 
assault by 
intimate partner 
4 years 4 None None 
P9 19 female EA N Some 
college 
US Parent 
committed 
suicide 
5 years 1 None None 
P10 18 female EA N Some 
college 
US Repeated sexual 
assault by 
intimate partner 
2 years >5 None Supportive 
P=Participant; EA=European-American, ME=Middle-Eastern, I=Indian; PR=Puerto-Rican; N=never married; M=married; 
US=undergraduate student; GS=graduate student; PT=employed part-time; FT=employed full-time; PTE=lifetime number of potentially 
traumatic events; A=antidepressant
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Table 2. 
 
Summary of Intervention Components 
 
Session Primary Target Content 
1 Psychoeducation 
and mindfulness 
strategies 
• Information on posttraumatic stress and common trauma 
reactions, including shame and self-blame 
• Information and instruction on basic mindfulness techniques 
(mindful breathing, grounding) 
• Homework: Practice Mindful Breathing and Grounding 
2 Self-compassion 
for everyday 
difficulties 
• Describe 3 emotion regulation systems 
• Define compassion  
• Build motivation to reduce self-criticism and build self-
compassion 
• Address misconceptions and fear of compassion with story of 
Critical Coach vs Compassionate Coach 
• Practice Self-Compassion Break exercise 
• Homework: Complete worksheet on misconceptions of 
compassion, practice Self-Compassion Break, write 
compassionate letter to self for an everyday difficulty (not 
trauma-related) 
3 Self-compassion 
for everyday 
difficulties 
• Continue building self-compassion for difficulties that are not 
trauma related, using compassionate scent, Sending 
Compassion exercise, and Perfect Nurturer exercise. 
• Homework: Practice Sending Compassion and Perfect 
Nurturer exercises 
4 Trauma-specific 
self-compassion 
• Identify worst moments during traumatic event 
• Practice revisiting trauma memory with perfect nurturer 
• Homework: Practice revisiting trauma memory with perfect 
nurturer 
5 Trauma-specific 
self-compassion 
• Identify trauma-related emotions and practice self-
compassionate response with Compassion Antidote exercise 
• Homework: Practice Compassion Antidote exercise, write 
compassionate letter to self about the traumatic event 
6 Review and 
wrap-up 
• Discuss/read compassionate letter to self 
• Review skills learned and participant’s progress 
• Make plan to continue practicing compassion in response to 
everyday difficulties and trauma memories 
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Table 3. 
PTSD and Shame Severity Change Scores with 95% CIs (lower limit, upper limit) 
 
Note. Each cell displays a change score (lower limit of change, upper limit of change). CI=Confidence 
interval; CS=change score; BL=change from first baseline score to last baseline score; TX=change from 
last baseline score to post-test (after Session 6); FU=change from last baseline to 4-wk follow-up. 
P=Participant; PCL-5=PTSD Checklist for DSM-5; ISS=Internalized Shame Scale. * indicates 
improvement on measure p<.05. ^ indicates worsening on measure p<.05 
  
 
PCL-5 
95%CI =CS ± 21.95 
ISS 
95%CI =CS ± 14.26 
P1   
BL 7 (-14.95, 28.95) 1 (-13.26, 15.26) 
TX -25 (-46.95, -3.05)* -35 (-49.26, -20.74)* 
FU -34 (-55.95, -12.05)* -43 (-57.26, -28.74)* 
P2   
BL -1 (-22.95, 20.95) 20 (5.74, 34.26)^ 
TX -41 (-62.95, -19.05)* -44 (-58.26, -29.74)* 
FU -39 (-60.95, -17.05)* -38 (-52.26, -23.74)* 
P3   
BL -17 (-38.95, 4.95) 16 (1.74, 30.26)^ 
TX 0 (-21.95, 21.95) -1 (-15.26, 13.26) 
FU -12 (-33.95, 9.95) -25 (-39.26, -10.74)* 
P4   
BL 6 (-15.95, 27.95) -1 (-15.26, 13.26) 
TX -43 (-64.95, -21.05)* -62 (-76.26, -47.74)* 
FU -50 (-71.95, -28.05)* -60 (-74.26, -45.74)* 
P5   
BL 16 (-5.95, 37.95) 43 (28.74, 57.26)^ 
TX -14 (-35.95, 7.95) -50 (-64.26, -35.74)* 
FU -24 (-45.95, -2.05)* -57 (-71.26, -42.74)* 
P6   
BL 14 (-7.95, 35.95) 15 (0.74, 29.26)^ 
TX -52 (-73.95, -30.05)* -57 (-71.26, -42.74)* 
FU -58 (-79.95, -36.05)* -66 (-80.26, -51.74)* 
P7   
BL 1 (-20.95, 22.95) 0 (-14.26, 14.26) 
TX -23 (-44.95, -1.05)* -22 (-36.26, -7.74)* 
FU -22 (-43.95, -0.05)* -15 (-29.26, -0.74)* 
P8   
BL -6 (-27.95, 15.95) 23 (8.74, 37.26)^ 
TX -23 (-44.95, -1.05)* -53 (-67.26, -38.74)* 
FU -25 (-46.95, -3.05)* -57 (-71.26, -42.74)* 
P9   
BL 11 (-10.95, 32.95) 0 (-14.26, 14.26) 
TX -25 (-46.95, -3.05)* -10 (-24.26, 4.26) 
FU -20 (-41.95, 1.95) -9 (-23.26, 5.26) 
P10   
BL 3 (-18.95, 24.95) -10 (-24.26, 4.26) 
TX -27 (-48.95, -5.05)* -31 (-45.26, -16.74)* 
FU -30 (-51.95, -8.05)* -34 (-48.26, -19.74)* 
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Table 4. 
Self-Blame and Self-Compassion Change Scores with 95% CIs (lower limit, upper limit) 
 
Note. Each cell displays a change score (lower limit of change, upper limit of change). CI=Confidence 
interval; CS=change score; BL=change from first baseline score to last baseline score; TX=change from 
last baseline score to post-test (after Session 6); FU=change from last baseline to 4-wk follow-up. 
P=Participant; PTCI-sb= Posttraumatic Cognitions Inventory Self-Blame subscale; SCS=Self-Compassion 
Scale. * indicates improvement on measure p<.05. ^ indicates worsening on measure p<.05 
  
 
PTCI-sb 
95%CI =CS ± 1.60 
SCS 
95%CI =CS ± .46 
P1   
BL 0.6 (-1, 2.2) 0.15 (-0.3, 0.61) 
TX -1.8 (-3.4, -0.2)* 1.12 (0.66, 1.57)* 
FU -4.8 (-6.4, -3.2)* 2.46 (2, 2.92)* 
P2   
BL 0.6 (-1, 2.2) -0.42 (-0.88, 0.04) 
TX -3.8 (-5.4, -2.2)* 1.08 (0.62, 1.54)* 
FU -2.8 (-4.4, -1.2)* 1.04 (0.58, 1.5)* 
P3   
BL -0.8 (-2.4, 0.8) 0.23 (-0.23, 0.69) 
TX -1.8 (-3.4, -0.2)* 0.15 (-0.3, 0.61) 
FU -2.8 (-4.4, -1.2)* 0.58 (0.12, 1.04)* 
P4   
BL 0 (-1.6, 1.6) -0.35 (-0.8, 0.11) 
TX -4.6 (-6.2, -3)* 2.81 (2.35, 3.27)* 
FU -4.8 (-6.4, -3.2)* 3.04 (2.58, 3.5)* 
P5   
BL 0.6 (-1, 2.2) -0.31 (-0.77, 0.15) 
TX -2.4 (-4, -0.8)* 1.31 (0.85, 1.77)* 
FU -3.6 (-5.2, -2)* 1.19 (0.73, 1.65)* 
P6   
BL 1.2 (-0.4, 2.8) -0.54 (-1, -0.08)^ 
TX -4.2 (-5.8, -2.6)* 3.12 (2.66, 3.57)* 
FU -4.2 (-5.8, -2.6)* 3.65 (3.2, 4.11)* 
P7   
BL 0 (-1.6, 1.6) -0.08 (-0.54, 0.38) 
TX -1.2 (-2.8, 0.4) 0.65 (0.2, 1.11)* 
FU -1.4 (-3, 0.2) 0.5 (0.04, 0.96)* 
P8   
BL 0 (-1.6, 1.6) -0.12 (-0.57, 0.34) 
TX -3.8 (-5.4, -2.2)* 1.96 (1.5, 2.42)* 
FU -4.2 (-5.8, -2.6)* 2.81 (2.35, 3.27)* 
P9   
BL 0.2 (-1.4, 1.8) 0 (-0.46, 0.46) 
TX -0.2 (-1.8, 1.4) 0.8 (0.34, 1.26)* 
FU -0.2 (-1.8, 1.4) 0.62 (0.16, 1.08)* 
P10   
BL -0.8 (-2.4, 0.8) 0.7 (0.24, 1.16)* 
TX -3 (-4.6, -1.4)* 2.4 (1.94, 2.86)* 
FU -3.2 (-4.8, -1.6)* 2.62 (2.16, 3.08)* 
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Table 5. 
Mindfulness and Positive and Negative Affect Change Scores with 95% CIs (lower limit, 
upper limit) 
 
Note. Each cell displays a change score (lower limit of change, upper limit of change). CI=Confidence 
interval; CS=change score; BL=change from first baseline score to last baseline score; TX=change from 
last baseline score to post-test (after Session 6); FU=change from last baseline to 4-wk follow-up. 
P=Participant; CAMS-R=Cognitive and Affective Mindfulness Scale-Revised; PA=Positive Affect; 
NA=Negative Affect. * indicates improvement on measure p<.05. ^ indicates worsening on measure p<.05
 
CAMS-R 
95%CI =CS ± 7.43 
PA 
95%CI =CS ± 9.53 
NA 
95%CI =CS ± 11.12 
P1    
BL -2 (-9.43, 5.43) -3 (-12.53, 6.53) 7 (-4.12, 18.12) 
TX 5 (-2.43, 12.43) -3 (-12.53, 6.53) -14 (-25.12, -2.88)* 
FU 18 (10.57, 25.43)* 6 (-3.53, 15.53) -18 (-29.12, -6.88)* 
P2    
BL -7 (-14.43, 0.43) -17 (-26.53, -7.47)^ -3 (-14.12, 8.12) 
TX 17 (9.57, 24.43)* 17 (7.47, 26.53)* -22 (-33.12, -10.88)* 
FU 12 (4.57, 19.43)* 15 (5.47, 24.53)* -19 (-30.12, -7.88)* 
P3    
BL -5 (-12.43, 2.43) -2 (-11.53, 7.53) -7 (-18.12, 4.12) 
TX -2 (-9.43, 5.43) -1 (-10.53, 8.53) -5 (-16.12, 6.12) 
FU 10 (2.57, 17.43)* 12 (2.47, 21.53)* -12 (-23.12, -0.88)* 
P4    
BL 0 (-7.43, 7.43) 2 (-7.53, 11.53) 10 (-1.12, 21.12) 
TX 19 (11.57, 26.43)* 17 (7.47, 26.53)* -26 (-37.12, -14.88)* 
FU 20 (12.57, 27.43)* 17 (7.47, 26.53)* -28 (-39.12, -16.88)* 
P5    
BL -3 (-10.43, 4.43) -5 (-14.53, 4.53) 13 (1.88, 24.12)^ 
TX 3 (-4.43, 10.43) 3 (-6.53, 12.53) -19 (-30.12, -7.88)* 
FU 9 (1.57, 16.43)* 9 (-0.53, 18.53) -22 (-33.12, -10.88)* 
P6    
BL -3 (-10.43, 4.43) 1 (-8.53, 10.53) 10 (-1.12, 21.12) 
TX 24 (16.57, 31.43)* 17 (7.47, 26.53)* -23 (-34.12, -11.88)* 
FU 28 (20.57, 35.43)* 18 (8.47, 27.53)* -30 (-41.12, -18.88)* 
P7    
BL 1 (-6.43, 8.43) 3 (-6.53, 12.53) -1 (-12.12, 10.12) 
TX 2 (-5.43, 9.43) 5 (-4.53, 14.53) -10 (-21.12, 1.12) 
FU 4 (-3.43, 11.43) 2 (-7.53, 11.53) -10 (-21.12, 1.12) 
P8    
BL -4 (-11.43, 3.43) 7 (-2.53, 16.53) 0 (-11.12, 11.12) 
TX 4 (-3.43, 11.43) 3 (-6.53, 12.53) -12 (-23.12, -0.88)* 
FU 13 (5.57, 20.43)* 8 (-1.53, 17.53) -15 (-26.12, -3.88)* 
P9    
BL 2 (-5.43, 9.43) 4 (-5.53, 13.53) 6 (-5.12, 17.12) 
TX 6 (-1.43, 13.43) 3 (-6.53, 12.53) -7 (-18.12, 4.12) 
FU 7 (-0.43, 14.43) 5 (-4.53, 14.53) -6 (-17.12, 5.12) 
P10    
BL 0 (-7.43, 7.43) 10 (0.47, 19.53)* -3 (-14.12, 8.12) 
TX 15 (7.57, 22.43)* 6 (-3.53, 15.53) -13 (-24.12, -1.88)* 
FU 20 (12.57, 27.43)* 14 (4.47, 23.53)* -14 (-25.12, -2.88)* 
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Table 6. 
 
Mean Summary Scores and Effect Sizes with 95% Confidence Intervals 
 
 Baseline 
 Treatment  Follow-Up 
Outcome 
variable M SD 
 M SD dtx 95% CI 
 M SD dfu 95% CI 
PCL 40.20 11.92  18.60 6.74 1.10 (0.54, 1.66)  11.95 6.31 2.26 (1.33, 3.19) 
ISS 59.65 10.59  33.05 19.87 1.03 (0.47, 1.60)  26.30 16.97 2.12 (1.27, 2.97) 
PTCI-sb 5.57 0.86  3.33 0.87 1.31 (0.66, 1.96)  2.73 1.02 2.61 (1.45, 3.77) 
CAMS-R 22.22 3.47  29.45 5.96 0.94 (0.42, 1.47)  33.45 5.78 2.21 (1.33, 3.09) 
PA 23.97 6.96  29.90 8.36 0.39 (0.05, 0.74)  32.70 7.35 1.07 (0.51, 1.62) 
NA 31.37 5.61  22.05 4.95 0.92 (0.46, 1.38)  17.40 3.65 2.14 (1.35, 2.92) 
SCS-Total 2.07 0.55  3.44 0.66 1.47 (0.83, 2.10)  3.71 0.80 2.28 (1.23, 3.33) 
SCS-sk 1.86 0.54  3.23 0.77 1.32 (0.80, 1.84)  3.66 0.84 2.30 (1.26, 3.34) 
SCS-sj 4.18 0.51  2.82 0.85 1.27 (0.71, 1.84)  2.49 0.98 2.01 (1.19, 2.82) 
SCS-ch 2.43 1.10  3.72 0.90 0.87 (0.40, 1.34)  3.85 1.12 1.30 (0.64, 1.95) 
SCS-i 3.89 0.87  2.38 0.70 1.21 (0.63, 1.79)  2.16 0.77 1.96 (1.03, 2.89) 
SCS-m 2.31 0.53  3.57 0.63 1.32 (0.76, 1.87)  3.74 0.86 1.87 (1.05, 2.69) 
SCS-oi 4.04 0.69  2.56 0.57 1.27 (0.73, 1.80)  2.30 0.73 2.17 (1.29, 3.05) 
 
Note. M=Mean; SD=Standard deviation; dtx= baseline vs treatment effect size; dfu= baseline vs follow-up effect size; CI=confidence interval; PCL-
5=PTSD Checklist for DSM-5; ISS=Internalized Shame Scale; PTCI-sb= Posttraumatic Cognitions Inventory Self-Blame subscale; CAMS-
R=Cognitive and Affective Mindfulness Scale-Revised; PA=Positive Affect; NA=Negative Affect; SCS-Total=Self-Compassion Scale, total score; SCS 
subscales: sk=self-kindness, sj=self-judgment, ch=common humanity, i=isolation, m-mindfulness, oi=over-identification. 
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Figure 1. 
Participant Flow 
 
Completed Online Screen 
(n=206) 
Assessed in-person for 
eligibility (n=25) 
Excluded  
(not eligible) 
(n=181)   
Randomized to complete 
weekly baseline 
assessments for 
 2, 4, or 6 weeks (n=17) 
Excluded (n=8) 
•  Inclusion criteria not met 
o  Shame not clearly 
tied to traumatic 
event (n=5) 
o  PCL-5 < 27 (n=1) 
•  Decided to start different 
type of therapy (n=1) 
•  Ongoing intimate partner 
violence (n=1) 
Dropped out before starting 
treatment (n=2) 
•  Too busy to participate (n=1) 
•  Not ready to address trauma 
(n=1) 
Completed intervention 
and all assessments (n=10) 
Withdrawn due to immediate 
and sustained symptom 
improvement on PCL-5 (n=2) Dropped out during treatment 
(n=3) 
•  Too busy to participate and not 
ready to address trauma (n=1) 
•  No reason given; did not 
respond to multiple attempts to 
schedule next treatment 
session (n=1) 
•  Decided to seek inpatient 
hospitalization and other 
outpatient treatment (n=1) 
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Figure 2. 
Shame and PTSD Symptom Severity 
 
Note. P=participant; B=baseline; T=treatment; F=follow-up. PCL-5 range is 0-80, ISS range is 0-96. 
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Figure 3. 
Self-Blame and Self-Compassion Scores 
 
Note. P=participant; B=baseline; T=treatment; F=follow-up. PTCI-sb range is 0-7, SCS range is 0-5.
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